Royalty Pharma plc - stock earnings
RPRX Upcoming estimated earnings
Date | Low Revenue | Average Revenue | High Revenue |
---|---|---|---|
May 7, 2024 BeforeMarket | 533.9 million | 643.6 million | 715.9 million |
RPRX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 494.3 million USD | 596.0 million USD |
2023Q3 | 72.1 million USD | 536.3 million USD |
2023Q2 | 227.6 million USD | 538.2 million USD |
2023Q1 | 340.8 million USD | 684.0 million USD |
2022Q4 | -610.2 million USD | 565.7 million USD |
2022Q3 | 217.8 million USD | 573.5 million USD |
2022Q2 | 304.5 million USD | 536.0 million USD |
2022Q1 | -39.9 million USD | 562.0 million USD |
2021Q4 | 7.9 million USD | 575.7 million USD |
2021Q3 | 101.9 million USD | 585.8 million USD |
2021Q2 | 440.8 million USD | 555.0 million USD |
2021Q1 | 69.1 million USD | 573.0 million USD |
2020Q4 | 171.0 million USD | 571.0 million USD |
2020Q3 | 291.0 million USD | 539.0 million USD |
2020Q2 | 442.1 million USD | 510.9 million USD |
2020Q1 | 71.2 million USD | 500.9 million USD |
2019Q4 | 1.4 billion USD | 457.5 million USD |
2019Q3 | 409.0 million USD | 464.3 million USD |
2019Q2 | 151.7 million USD | 457.6 million USD |
2019Q1 | 367.4 million USD | 434.9 million USD |
2017Q3 | -1.6 million USD | ? USD |
2017Q2 | -2.2 million USD | ? USD |
2017Q1 | -5.9 million USD | ? USD |
2016Q4 | -4.0 million USD | ? USD |
2010Q4 | ? USD | 244000 USD |
2005Q1 | ? USD | 4000 USD |
2004Q3 | ? USD | 1000 USD |
2004Q2 | ? USD | 53000 USD |
2004Q1 | ? USD | 64000 USD |
2003Q4 | ? USD | 136000 USD |
2003Q3 | ? USD | 122000 USD |
2003Q2 | ? USD | 216000 USD |
2003Q1 | ? USD | 121000 USD |
2002Q4 | ? USD | 103000 USD |
2002Q3 | 3.4 million USD | 3.4 million USD |
2002Q2 | ? USD | 529000 USD |
2002Q1 | ? USD | 528000 USD |
2001Q4 | ? USD | 529000 USD |
2001Q3 | ? USD | 558000 USD |
2001Q2 | ? USD | 564000 USD |
2001Q1 | ? USD | 684000 USD |
2000Q4 | ? USD | 700000 USD |
2000Q3 | ? USD | 564000 USD |
2000Q2 | ? USD | 539000 USD |
2000Q1 | ? USD | 548000 USD |
RPRX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 1.1 billion USD | 2.4 billion USD |
2022 | 42.8 million USD | 2.2 billion USD |
2021 | 478.8 million USD | 2.3 billion USD |
2020 | 555.0 million USD | 2.1 billion USD |
2019 | 2.3 billion USD | 1.8 billion USD |
2018 | 1.4 billion USD | 1.8 billion USD |
2017 | 1.2 billion USD | 1.6 billion USD |
2016 | -17.3 million USD | ? USD |
2015 | -29.2 million USD | ? USD |
2014 | -32.5 million USD | ? USD |
2010 | ? USD | 244000 USD |
2005 | ? USD | 4000 USD |
2004 | ? USD | 118000 USD |
2003 | ? USD | 595000 USD |
2002 | ? USD | 4.5 million USD |
2001 | ? USD | 2.3 million USD |
2000 | ? USD | 2.4 million USD |
RPRX
Price: 30.37USD
52 week price:
Dividend Yield: 2.81%
5-year range yield:
Forward Dividend Yield: 2.76%
Payout Ratio: 215.38%
Payout Ratio Range:
Dividend Per Share: 0.84 USD
Earnings Per Share: 0.39 USD
P/E Ratio: 73.59
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Ebitda: -16.0 millionMarket Capitalization: 17.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 5
DGR3: 7.76%